Original Source(s)
Related Content
Second Primary Cancer Risk Shifts Over Time
US registry study finds overall declines but rising risk in lung, melanoma, and older survivor groups
May 5, 2026
-
5 min
FDA Clears Golimumab Biosimilars
New biosimilars enter the market with pharmacy-level substitution eligibility for rheumatology and gastroenterology indications.
May 18, 2026
-
2 min
Smartwatch May Track AD Status in Children
Wearable-derived scratching measures align with disease activity and short-term treatment response in pediatric patients with atopic dermatitis.
May 5, 2026
-
3 min